Gaucher disease type 1 and 3: ERT shows promising long-term efficacy
Dr Pramod Mistry recently sat down with Check Rare to discuss and provide an in-depth insight into the long-term efficacy of Enzyme Replacement Therapy (ERT) for Gaucher Disease types 1 and 3.
The three types of Gaucher disease: all you need to know
Dr Pramod Mistry recently sat down with Check Rare to discuss and provide an in-depth insight into Gaucher disease Type 1, Type 2 and Type 3.
Gaucher disease type 3: a history revealing breakthrough treatment
Dr Pramod Mistry recently sat down with Check Rare to provide a brief history of Gaucher disease and an overview of how persons with Gaucher disease type 3 are managed.
The 6th International Forum of Lysosomal Disorders
Dr Pramod Mistry will be speaking at the 6th International Forum of Lysosomal Disorders which will take place in Tokyo, Japan between 30th March to 1st April 2023. Learn more.
An interactive program: deciphering uncommon hematological disorders
Dr Pramod Mistry - program chairperson at the "D" is for Diagnosis: Deciphering Uncommon Hematologic Disorders Through the Eyes of a Detective - an interactive program.
17th Annual Italian meeting of Gaucher experts held in Genova, Italy
Dr Pramod Mistry - keynote speaker at the 17th Annual Italian meeting of Gaucher experts held in Genova, Italy.
New insights into the molecular mechanisms underlying Gaucher disease
Researchers at Yale School of Medicine have found that new disease pathways involving more than one cell type lead to Type 1 Gaucher disease
Type 1 Gaucher Disease: breakthrough research
Researchers at Yale School of Medicine have found that new disease pathways involving more than one cell type lead to Type 1 Gaucher disease